BELLICUM PHARMACEUTICALS, INC (33)

Browse by Contract Category

Contracts

License Agreement by and between the Registrant and BioVec Pharma, Inc., dated as of June 4, 2015 (Filed With SEC on August 12, 2021)
Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on June 17, 2021)
Cancer Research Grant Contract, dated July 27, 2011, by and between the Registrant and the Cancer Prevention and Research Institute of Texas (Filed With SEC on November 5, 2020)
Form of warrant to purchase common stock (Filed With SEC on November 2, 2020)
Supply Agreement by and between Registrant and Miltenyi Biotech GmbH, dated March 27, 2019 (Filed With SEC on May 7, 2019)
Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on May 14, 2021)
Forms of stock option grant notice, stock option agreement and notice of exercise, and forms of restricted stock award notice and restricted stock award agreement under the... (Filed With SEC on March 31, 2021)
Exclusive License Agreement, effective November 1, 2014, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)
Exclusive License Agreement, dated June 27, 2010, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)
Exclusive License Agreement, dated March 20, 2008, by and between the Registrant and Baylor College of Medicine (Filed With SEC on November 5, 2020)
Omnibus Amendment Agreement, dated October 3, 2014, by and between Registrant and ARIAD Pharmaceuticals, Inc (Filed With SEC on November 5, 2020)
Amended and Restated License Agreement (Filed With SEC on November 5, 2020)
Form of pre-funded warrant (Filed With SEC on November 2, 2020)
Underwriting Agreement, dated October 29, 2020, by and between Bellicum Pharmaceuticals and H.C. Wainwright & Co (Filed With SEC on November 2, 2020)
Bellicum Pharmaceuticals, Inc. 2019 Equity Incentive Plan, as amended (Filed With SEC on August 6, 2020)
Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on August 6, 2020)
Second Amendment to Loan and Security Agreement, dated March 31, 2020, by and between the Registrant and Oxford Finance LLC (Filed With SEC on May 7, 2020)
Asset Purchase Agreement, dated January 17, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)
Forms of stock option grant notice, stock option agreement and notice of exercise, and forms of restricted stock award notice and restricted stock award agreement under the... (Filed With SEC on March 12, 2020)
First Amendment to Asset Purchase Agreement, dated February 21, 2020, by and between the Registrant and The University of Texas M.D. Anderson Cancer Center (Filed With SEC on March 12, 2020)
First Amendment to Loan and Security Agreement, dated December 24, 2019, by and between the Registrant and Oxford Finance LLC (Filed With SEC on March 12, 2020)
Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2020)
Description of Securities (Filed With SEC on March 12, 2020)
Securities Purchase Agreement, dated August 16, 2019, by and among the Company and the institutional investors named therein (Filed With SEC on August 19, 2019)
Form of Warrant issued in private placement (Filed With SEC on August 19, 2019)
Form of Warrant issued in public offering (Filed With SEC on August 19, 2019)
Underwriting Agreement, dated August 16, 2019, by and among the Company, Jefferies LLC and Wells Fargo Securities, LLC, as representative of the several underwriters identified... (Filed With SEC on August 19, 2019)
Bellicum Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on May 7, 2019)
Bellicum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on March 12, 2019)
Employment Agreement by and between Registrant and Aaron Foster, Ph.D., effective June 1, 2016 (Filed With SEC on March 12, 2019)
Employment Agreement by and between Registrant and Atabak Mokari, effective November 19, 2018 (Filed With SEC on March 12, 2019)
Employment Agreement by and between Registrant and Rosemary Williams, effective January 1, 2017 (Filed With SEC on March 12, 2019)
Bellicum Pharmaceuticals, Inc. 2014 Equity Incentive Plan, as amended (Filed With SEC on March 12, 2019)